Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Merck Buys Peloton On Eve Of IPO Expands Kidney Cancer Portfolio

$
0
0
Investors in Peloton which has the only clinicalstage HIF2 inhibitor will get back 3.5 times the $304m in venture capital...&160;&160;&160;&160;

Viewing all articles
Browse latest Browse all 2985

Trending Articles